Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)
Clinical trial NCT03614156 · TERMINATED
Trial details
- NCT number
- NCT03614156
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-02
- Primary completion
- 2019-07-11
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.